13F-HR filed by SAMSARA BIOCAPITAL, LLC
SAMSARA BIOCAPITAL, LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 27 holding rows worth $765,928,969.
- Accession
- 0001744967-25-000004
- Filer
- CIK 1744967
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 27 entries on the cover page, a total value of $765,928,969 stated on the cover page (in dollars after the unit check, H1), rows summing to $765,928,969 with VALUE read as dollars as filed, 13F file number 028-19375. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 6,263,151 | $237,498,686 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 5,612,896 | $209,024,247 | dollars as filed | |
| KALARIS THERAPEUTICS INC | 482929106 | COM | 11,448,081 | $66,169,908 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 3,149,128 | $59,235,098 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 1,717,127 | $29,757,811 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 4,801,370 | $19,157,466 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 962,154 | $18,098,117 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 6,130,268 | $16,122,605 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 343,012 | $15,977,499 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 2,500,000 | $13,975,000 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 209,634 | $13,141,955 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 675,504 | $10,314,946 | dollars as filed | |
| VTV THERAPEUTICS INC | 918385204 | CL A NEW | 374,461 | $8,743,664 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 3,768,035 | $7,799,832 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 571,142 | $6,710,919 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 81,165 | $6,663,647 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 75,442 | $6,405,026 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 531,163 | $4,583,937 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 584,849 | $3,614,367 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 207,901 | $3,550,949 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 241,400 | $3,110,439 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 30,285 | $3,058,482 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 2,196,814 | $1,907,713 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 135,573 | $1,018,153 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702203 | COM NEW | 48,830 | $259,776 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 133,333 | $26,947 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 99,999 | $1,780 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001744967-25-000004 | this filing | 2025-11-14 | acceptance time not in the bulk data set |